Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A protein kinase is an enzyme that selectively modifies other proteins by covalently attaching phosphate groups to them—a process known as phosphorylation. This modification typically occurs on specific amino acids with free hydroxyl groups, most commonly serine, threonine, or tyrosine residues. Phosphorylation often results in a functional change of the target protein (the substrate), affecting its enzymatic activity, cellular localization, or interactions with other proteins. Protein kinases are central regulators of cellular pathways and signal transduction. They control diverse processes such as cell growth, differentiation, metabolism, apoptosis, gene expression regulation, mitosis, and responses to external stimuli. In humans alone there are about 500 protein kinase genes—about 2% of all human genes—and up to 30% of all human proteins may be modified by kinase activity.
Inhibition of phosphorylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Kinase (PK).